Sec. 2. Immediate purchase orders of COVID–19 medical testing components, materials, and supplies
184 words·~1 min read·
/bill/116/hr/6609/ih/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 24 hours after the date of the enactment of this Act, the President shall issue any necessary purchase orders for a program of the highest national urgency (commonly known as a DX purchase order) pursuant to Department of Defense Directive 4400.1 to procure all necessary components, materials, and supplies to conduct molecular and serological COVID–19 medical testing nationwide under authorities provided by the Defense Production Act of 1950 ( 50 U.S.C. 4501 et seq.). All components, materials, and supplies described in subsection
(a)must have received prior approval of the Center for Disease Control and Prevention or have received emergency use authorization from the Food and Drug Administration for the detection of coronavirus disease 2019 (commonly known as COVID–19 ). The requirements of sections 301(d)(1)(A) and 303(a)(6) of the Defense Production Act of 1950 ( 50 U.S.C. 4531(d)(1)(A) ; 4533(a)(6)) are waived for purposes of this section. Amounts available in the Defense Production Act Fund (established under section 304 of the Defense Production Act of 1950 ( 50 U.S.C. 4534 )) shall be made available for purchases made under this section.
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Sec. 2
Immediate purchase orders of COVID–19 medical testing components, materials, and supplies
Cites 3Cited by 0 across 0 sources